Binary toxin and death after Clostridium difficile infection. - Wikidata - awgldk - TriplyDB

Binary toxin and death after Clostridium difficile infection.

Binary toxin and death after Clostridium difficile infection.

http://www.wikidata.org/entity/Q35980156

about

Surgical Management of Clostridium difficile Colitis Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections WSES guidelines for management of Clostridium difficile infection in surgical patients Host recognition of Clostridium difficile and the innate immune response.The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile.Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.Clostridium difficile infection in older adults Incidence of diarrhea by Clostridium difficile in hematologic patients and hematopoietic stem cell transplantation patients: risk factors for severe forms and death.Clostridium and bacillus binary enterotoxins: bad for the bowels, and eukaryotic being.The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Clostridium difficile in the Long-Term Care Facility: Prevention and Management Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B Multiplex PCR method for detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and internal in-frame deletion of tcdC DNA-Microarray-based Genotyping of Clostridium difficile.A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011.A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.Clostridium difficile toxins: mediators of inflammation.Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study.Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.Clostridium difficile ribotype does not predict severe infection.Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.Clostridial binary toxins: iota and C2 family portraits.Hype or hypervirulence: a reflection on problematic C. difficile strains.Molecular methods in the diagnosis of Clostridium difficile infections: an update.Vaccines against Clostridium difficile.Antibodies for treatment of Clostridium difficile infection.Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.Description and validation of a new automated surveillance system for Clostridium difficile in Denmark.

P2860

Q24618413-FF273366-9BA4-42D3-934E-4AEE909FD398 Q26752760-3E9C7AD9-E8BC-456A-8192-4B9B55E40B8E Q26795429-104230D3-D28E-43D1-8AE8-8205CCA66F9D Q27026464-654EAE10-CD33-4064-B4D4-4FD716EBC29E Q30276036-7CA25F91-8641-4FF0-8596-A4319E9309E7 Q30300865-971B8927-8032-4C29-9DC7-ED21E69F2FFB Q30300885-A869623D-AAAD-4551-B415-E7C4370D41BA Q33728296-3B096178-2DF3-4540-86A6-C8D61DE02C81 Q33771594-7880E67C-ECE7-411C-A52D-BE2B9ADF1B27 Q34040801-E402F8CD-E7CB-4B2D-AE99-DEA32EBE1B4D Q34263384-DD36DD13-B551-4010-8883-CE999BD9F238 Q34623572-35C908CB-948D-4066-841F-516B10D5BBA0 Q35036237-1D87D998-E4C4-4CA0-BD24-7E584BBEBE30 Q35044119-C57E46E2-0F8E-4B9E-8F12-FB3F137D5AE8 Q35065783-A9FD82C4-8AD5-444A-B1C2-176E1AD7EE29 Q35112200-DCA36FA7-15CA-4C2A-96BC-4273B16761E6 Q35599031-1433C651-06CB-465B-8A88-2007A36F7FA3 Q35737725-A4BC333D-227A-4C08-9D0F-7445BDB4B3B2 Q35773934-381AE683-8C18-411A-AB25-39AD3588AA9C Q35898112-60C5F632-F071-4754-B52F-1CB999FA794B Q35921501-893CC97D-D9BC-4B18-8F44-CF99E877DE02 Q35955254-3BA7128B-236F-4D68-B694-4DAAD9EC0D98 Q36019350-18F09EC7-A31E-4F45-9B84-A71FFAA39AED Q36072072-F26D1471-F6CD-4ABF-888F-515E747D0CEA Q36099373-6D73399F-8E35-474D-81A9-0DA216DAFDBC Q36123790-28C57C7D-FEC8-4152-A5F3-AFACEFF6E555 Q36190012-EC2EFC6A-C20A-4BC6-A036-38D518B6C701 Q36261170-A53FABA2-DE99-441E-A045-AEBC745DB008 Q36402112-671BBFC7-898D-44D5-8320-8C38D17D5031 Q36408941-A870C22B-83B8-4EA3-AF14-06ED11195171 Q37014160-8520429C-5543-47F2-AFFD-E4159A046AF9 Q37192173-434DCF61-8F63-46CB-8C0B-5A80F158C530 Q37680481-7782C54E-42CF-41BB-BEB2-06F9B26AB615 Q38037529-D008427F-F862-46F4-A55C-1D5C095DF27B Q38141579-740E5A86-C110-4925-B814-C680B5EE605C Q38142247-D37B3924-35BF-4629-A790-3220F797811D Q38196682-9B7CF5B4-0C61-4809-8747-C2248D72923B Q38208794-6FB3BFC3-1A48-42DF-BD29-AA1F3482A9B9 Q38538221-8E2A465F-60CB-46B7-ACB0-F3D0E198946A Q38687899-5C2663C6-5A42-4C6C-8DDC-48D2211ED99E

P2860

Binary toxin and death after Clostridium difficile infection.

http://www.wikidata.org/entity/Q35980156

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Binary toxin and death after Clostridium difficile infection.

@ast

Binary toxin and death after Clostridium difficile infection.

@en

type

label

Binary toxin and death after Clostridium difficile infection.

@ast

Binary toxin and death after Clostridium difficile infection.

@en

prefLabel

Binary toxin and death after Clostridium difficile infection.

@ast

Binary toxin and death after Clostridium difficile infection.

@en

P1433

Q35980156-E5771452-786F-4A7F-85EE-2E244B0303AC

P1476

Q35980156-7FA0A10D-8AE7-498D-BBFB-DA82BCEF1614

P2093

Q35980156-42635BB8-0360-4F33-86CF-D97342CA40C2

Q35980156-433B9405-8F3E-4CE8-9633-98557D0BDBFD

Q35980156-4F21CF57-317C-4399-8ED4-16C09FCD5DC9

P2860

Q35980156-05E1DB22-B144-424B-8AA0-C455BFB4A80D

Q35980156-06D11CBB-A643-4521-94DE-DDE3B62AB7B6

Q35980156-0728A0C6-D1B2-4B6A-9AE7-C3135A279885

Q35980156-09818BEA-6FDF-4B1B-9DF9-10C1CBE4AAF6

Q35980156-09CC552B-BE7A-4D6C-9EC6-D24DAB99CC4F

Q35980156-13EDECD9-B51C-41FA-8CFA-4C12CE14BDC5

Q35980156-1C9FAA83-4F59-4547-98FA-B6F764DA00D3

Q35980156-2183270D-C713-4321-B3CE-32385577741F

Q35980156-25A9FF4C-A97A-45BA-A65E-D542817FFCB3

Q35980156-2925207E-8429-4690-B4CA-9D1E3F59379F

P304

Q35980156-F743B529-BFC7-4EA1-A9CF-8E78BD32CEC6

P31

Q35980156-00F94A6E-83C1-4891-841B-00107B25BEAC

P356

Q35980156-35590EAF-570A-4B2C-9764-61A97A6AB866

P433

Q35980156-51E7AD38-CF51-4BFE-8B10-9C40288ED80F

P478

Q35980156-204EC495-E741-418A-B910-654323D70D75

P50

Q35980156-AA7EBD1B-B17F-4F53-9DFA-944E4FF95EDF

P577

Q35980156-E7768BD7-FD99-4646-8B03-77AE2BC93B23

P5875

Q35980156-5AA56D41-7FBE-48E5-8F5F-C44B98C7A7B4

P698

Q35980156-AC0E3F33-3E2B-4CEC-A861-FE319DBFE78E

P921

Q35980156-2EEFB334-3BE8-49FB-A62B-FE5FD00FBDE0

P932

Q35980156-A25BA6D1-0953-466C-AF20-EBB1D3052A0A

P356

P1433

Emerging Infectious Diseases

P1476

Binary toxin and death after Clostridium difficile infection.

@en

P2093

Katharina E P Olsen

http://www.w3.org/2001/XMLSchema#string

Marianne K Kjeldsen

http://www.w3.org/2001/XMLSchema#string

Sabrina Bacci

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria

Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.

Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

The role of toxin A and toxin B in Clostridium difficile infection.

The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Glucosylation of Rho proteins by Clostridium difficile toxin B.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Risk factors for Clostridium difficile infection.

Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

P304

976-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID/1706.101483

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51486254

http://www.w3.org/2001/XMLSchema#string

P698

21749757

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3358205

http://www.w3.org/2001/XMLSchema#string